Physician profile
Ranjani Panda
NPI 1457929960
$8,893.64
in general payments reported to CMS, 2019-2025
25 companies · $3,185 in 2025
The $3,185 reported for 2025 was more than what 98% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $493 · 2022: $840 · 2023: $1,594 · 2024: $2,782 · 2025: $3,185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,036 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $400 · Education: $124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,036.40 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $400.00 |
| Education | $124.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,447.52 | 2023-2025 | Miebo, Xiidra, Infuse |
| Mallinckrodt Hospital Products INC. | $1,264.60 | 2021-2025 | Acthar |
| Sun Pharmaceutical Industries INC. | $868.58 | 2022-2025 | Cequa |
| Tarsus Pharmaceuticals, INC. | $659.95 | 2024-2025 | Xdemvy |
| Biotissue Holdings INC. | $640.57 | 2023-2025 | |
| Abbvie INC. | $470.55 | 2022-2025 | |
| Dompe US, INC. | $455.98 | 2021-2025 | Oxervate |
| Amgen INC. | $416.12 | 2024-2025 | Tepezza |
| Alcon Vision LLC | $380.38 | 2023-2025 | Rocklatan, Tryptyr, Hydrus Microstent |
| Allergan, INC. | $330.63 | 2021-2022 | |
| Notal Vision, INC. | $248.41 | 2025 | Foresee Home |
| Horizon Therapeutics Plc | $241.48 | 2022-2023 | Tepezza |
| Harrow Eye, LLC | $225.43 | 2024-2025 | Vevye |
| Oyster Point Pharma, INC. | $166.19 | 2022-2025 | Tyrvaya |
| Thea Pharma INC. | $133.27 | 2023-2025 | Iyuzeh |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rxsight INC | $128.27 | 2024-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Light Adjustable Lens (Lal) |
| New World Medical,INC. | $123.77 | 2023 | |
| Novartis Pharmaceuticals Corporation | $123.65 | 2022-2023 | |
| Glaukos Corporation | $123.27 | 2021 | |
| Kala Pharmaceuticals, INC. | $116.27 | 2022 | |
| Aerie Pharmaceuticals, INC. | $91.09 | 2021 | |
| Tearlab Corp | $77.90 | 2024 | Scoutpro Osmolarity System |
| Quidel Corporation | $74.77 | 2023 | |
| Rayner Intraocular Lenses Limited | $66.19 | 2023-2025 | Rayone Aspheric, Rayone Spheric, Rayone Emv |
| Johnson & Johnson Surgical Vision, INC. | $18.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ranjani Panda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.